MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the year ending 2025-12-31, KNSA has $763,633K in assets. $196,027K in debts. $165,596K in cash and cash equivalents.

Balance Sheets Overview

Current Ratio
378.76%
Quick Ratio
339.32%
Cash Ratio
118.98%
Debt to Asset Ratio
25.67%
Unit: Thousand (K) dollars
Assets Breakdown
    • Short-term investments
    • Deferred tax assets
    • Cash and cash equivalents
    • Others
Liabilities Breakdown
    • Additional paid-in capital
    • Accumulated deficit
    • Accrued collaboration expenses
    • Others

Balance Sheets
2025-12-31
Cash and cash equivalents
165,596
Short-term investments
248,478
Accounts receivable, net
15,594
Inventory
54,895
Prepaid expenses and other current assets
42,614
Total current assets
527,177
Property and equipment, net
1,943
Operating lease right-of-use assets
9,807
Other long-term assets
11,307
Intangible asset, net
15,250
Deferred tax assets
198,149
Total assets
763,633
Accounts payable
2,028
Accrued collaboration expenses
70,015
Accrued expenses
42,020
Operating lease liabilities
2,987
Other current liabilities
22,134
Total current liabilities
139,184
Non-current deferred revenue
31,811
Non-current operating lease liabilities
6,510
Other long-term liabilities
18,522
Total liabilities
196,027
Ordinary shares value-Common Class A
12
Ordinary shares value-Common Class B
1
Ordinary shares value-Common Class A1
4
Ordinary shares value-Common Class B1
4
Additional paid-in capital
1,029,748
Accumulated other comprehensive loss
-25
Accumulated deficit
-462,138
Total shareholders' equity
567,606
Total liabilities and shareholders' equity
763,633
Unit: Thousand (K) dollars (except for numbers of shares and EPS).

Time Plot

Show the time plot by selecting a row from the table.

Balance Sheets

Short-term investments$248,478K Cash and cashequivalents$165,596K Inventory$54,895K Prepaid expenses andother current assets$42,614K Accounts receivable, net$15,594K Total current assets$527,177K Deferred tax assets$198,149K Intangible asset, net$15,250K Other long-termassets$11,307K Operating leaseright-of-use assets$9,807K Property and equipment,net$1,943K Total assets$763,633K Total liabilities andshareholders' equity$763,633K Total shareholders'equity$567,606K Total liabilities$196,027K Accumulated deficit-$462,138K Accumulated othercomprehensive loss-$25K Additional paid-in capital$1,029,748K Total currentliabilities$139,184K Non-current deferredrevenue$31,811K Other long-termliabilities$18,522K Non-current operating leaseliabilities$6,510K Ordinary sharesvalue-Common Class A$12K Ordinary sharesvalue-Common Class B1$4K Ordinary sharesvalue-Common Class A1$4K Ordinary sharesvalue-Common Class B$1K Accrued collaborationexpenses$70,015K Accrued expenses$42,020K Other currentliabilities$22,134K Operating leaseliabilities$2,987K Accounts payable$2,028K

Kiniksa Pharmaceuticals International, plc (KNSA)

Kiniksa Pharmaceuticals International, plc (KNSA)